Renal Phosphate Control as a Reliable Predictive Factor of Stone Recurrence
Abstract
Purpose:
Recent studies have suggested a defect in phosphate balance as a significant underlying cause of calcium urolithiasis. In this study we assessed the influence of decreased renal phosphate reabsorption capacity on urinary metabolic abnormalities as well as on stone recurrence.
Materials and Methods:
A database of patient history, and serum and urine chemistry studies was analyzed for 950 consecutive stone formers and 91 normal controls. The maximal reabsorption of phosphate by the glomerular filtration rate was calculated, and the effect of maximal reabsorption of phosphate by the glomerular filtration rate on stone metabolites and stone recurrence was determined. A value of maximal reabsorption of phosphate by the glomerular filtration rate lower than 1.83 mg/dl was defined as a low rate. Of the stone formers 266 (28.0%) who had been followed for more than 36 months (median 49, range 2 to 152) were included in the recurrence analysis.
Results:
Maximal reabsorption of phosphate by the glomerular filtration rate was significantly less in stone formers compared to normal controls, and was negatively correlated with the urinary excretion of uric acid, calcium and phosphate. Of the stone formers 13.1% (124 of 950) had a low maximal reabsorption of phosphate by the glomerular filtration rate as well as a higher prevalence of hypercalciuria and hyperuricosuria than individuals with normal maximal reabsorption of phosphate by the glomerular filtration rate. The multivariate Cox regression model revealed that the low maximal reabsorption of phosphate by the glomerular filtration rate (hazards ratio 1.685, 95% CI 1.040–2.730, p = 0.034) was a strong predictor of stone recurrence in stone formers.
Conclusions:
This study demonstrated that the renal phosphate reabsorption capacity was significantly decreased in stone formers compared to normal controls, and that a low maximal reabsorption of phosphate by the glomerular filtration rate was associated with hypercalciuria and hyperuricosuria. Furthermore, renal phosphate handling was an independent predictive determinant for recurrence in stone formers.
References
- 1 : Incidence of upper urinary tract stones. Miner Electrolyte Metab1987; 13: 220. Google Scholar
- 2 : The hypercalciurias: Causes, parathyroid functions, and diagnostic criteria. J Clin Invest1974; 54: 387. Google Scholar
- 3 : The pathogenesis and treatment of kidney stones. N Engl J Med1992; 327: 1141. Google Scholar
- 4 : Inappropriate phosphate excretion in idiopathic hypercalciuria: the key to a common cause and future treatment?. J Clin Pathol1996; 49: 881. Google Scholar
- 5 : “Idiopathic” hypercalciuria and hereditary hypophosphatemic rickets: Two phenotypical expressions of a common genetic defect. N Engl J Med1987; 316: 125. Google Scholar
- 6 : Frequency of renal phosphate leak among patients with calcium nephrolithiasis. Kidney Int2001; 60: 272. Google Scholar
- 7 : Renal phosphate leak in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Urol Res2003; 31: 378. Google Scholar
- 8 : Nephrolithiasis: site of the initial solid phase. J Clin Invest2003; 111: 602. Google Scholar
- 9 : Calcium phosphate-induced renal epithelial injury and stone formation: involvement of reactive oxygen species. Kidney Int2003; 64: 1283. Google Scholar
- 10 : Sodium-hydrogen exchanger regulatory factor-1 interacts with mouse urate transporter 1 to regulate renal proximal tubule uric acid transport. J Am Soc Nephrol2007; 18: 1419. Google Scholar
- 11 : Longitudinal study of urinary excretion of phosphate, calcium, and uric acid in mutant NHERF-1 null mice. Am J Physiol Renal Physiol2006; 290: F838. Google Scholar
- 12 : Nomogram for derivation of renal threshold phosphate concentration. Lancet1975; 2: 309. Google Scholar
- 13 : Metabolic evaluation of stone disease patients: a practical approach. J Endourol1999; 13: 669. Google Scholar
- 14 : Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats. J Am Soc Nephrol2005; 16: 417. Google Scholar
- 15 : Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats. Kidney Int2000; 57: 550. Google Scholar
- 16 : Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc Natl Acad Sci U S A1998; 95: 5372. Google Scholar
- 17 : Regulation of Na/Pi transporter in the proximal tubule. Annu Rev Physiol2003; 65: 531. Google Scholar
- 18 : Role of uric acid in different types of calcium oxalate renal calculi. Int J Urol2006; 13: 252. Google Scholar
- 19 : Decreased renal phosphate threshold in patients with gout. Nephron1992; 62: 142. Google Scholar
- 20 : Dipyridamole decreases renal phosphate leak and augments serum phosphorus in patients with low renal phosphate threshold. J Am Soc Nephrol1998; 9: 1264. Google Scholar
